Literature DB >> 28509241

A case of encapsulating peritoneal sclerosis presented shortly after renal transplantation.

Georgios Spanos1, Haralampos V Harissis2, Evangelia Dounousi3, Michalis Mitsis2, Haralampos Pappas3, Georgios K Georgiou2, Kostas C Siamopoulos3, Michalis Fatouros2.   

Abstract

Encapsulating peritoneal sclerosis (EPS) is a rare but serious complication of peritoneal dialysis (PD), characterized by extensive intraperitoneal fibrosis and encasement of bowel loops. It typically associates with long-term PD and progressive loss of ultrafiltration. The management of EPS has evolved substantially from the original report of this entity and now includes immunosuppressive agents, antifibrotic agents, nutritional support, and surgical intervention. Although the exact cause of this condition remains obscure and despite the possible positive effect of immunosuppression on EPS, it has been described in the post-transplant setting upon the discontinuation of PD. We report such a case of a former PD patient who presented with EPS a month after renal transplantation. This article will highlight the current views regarding the management of post-transplant EPS and introduce the problem of long-term PD patients on the deceased-donor transplant waiting list.

Entities:  

Keywords:  Encapsulating peritoneal sclerosis; Immunosuppression; Peritoneal dialysis; Transplantation

Year:  2013        PMID: 28509241      PMCID: PMC5411535          DOI: 10.1007/s13730-013-0079-9

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  23 in total

Review 1.  Mechanisms and interventions in peritoneal fibrosis.

Authors:  Yasuhiko Tomino
Journal:  Clin Exp Nephrol       Date:  2011-09-21       Impact factor: 2.801

2.  The role of peritoneal lavage and the prognostic significance of mesothelial cell area in preventing encapsulating peritoneal sclerosis.

Authors:  Tadashi Yamamoto; Kyoko Nagasue; Senji Okuno; Tomoyuki Yamakawa
Journal:  Perit Dial Int       Date:  2010-03-25       Impact factor: 1.756

Review 3.  Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: diagnosis, predictive markers, treatment, and preventive measures.

Authors:  Yoshindo Kawaguchi; Akira Saito; Hideki Kawanishi; Masaaki Nakayama; Masanobu Miyazaki; Hidetomo Nakamoto; Anders Tranaeus
Journal:  Perit Dial Int       Date:  2005-04       Impact factor: 1.756

Review 4.  Posttransplant encapsulating peritoneal sclerosis: a worrying new trend?

Authors:  Marien W J A Fieren; Michiel G H Betjes; Mario R Korte; Walther H Boer
Journal:  Perit Dial Int       Date:  2007 Nov-Dec       Impact factor: 1.756

5.  Successful surgical management of encapsulating peritoneal sclerosis.

Authors:  Hideki Kawanishi; Hiroshi Watanabe; Misaki Moriishi; Shinichiro Tsuchiya
Journal:  Perit Dial Int       Date:  2005-04       Impact factor: 1.756

Review 6.  A collaborative approach to understanding EPS: the European perspective.

Authors:  Angela M Summers; Alferso C Abrahams; M Dominik Alscher; Michiel Betjes; Elisabeth W Boeschoten; Niko Braun; Paul E C Brenchley; Simon Davies; Louese Dunn; Lyda Engelsman; Marien Fieren; Guido Garosi; Eric Goffin; Lara Heuveling; Mario Korte; Bengt Lindholm; Peter Rutherford; Dirk Struijk; Marion Verduijn; Christian Verger; Ralf Westerhuis
Journal:  Perit Dial Int       Date:  2011 May-Jun       Impact factor: 1.756

7.  Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: results of the Dutch Multicentre EPS Study.

Authors:  Mario R Korte; Marien W Fieren; Denise E Sampimon; Hester F Lingsma; Willem Weimar; Michiel G H Betjes
Journal:  Nephrol Dial Transplant       Date:  2010-06-27       Impact factor: 5.992

8.  Prognosis of patients on continuous ambulatory peritoneal dialysis (CAPD) for over 10 years.

Authors:  Takafumi Toyohara; Yoshifumi Ubara; Yasushi Higa; Tatsuya Suwabe; Junichi Hoshino; Keiichi Sumida; Rikako Hiramatsu; Motonori Nagasawa; Eiko Hasegawa; Masayuki Yamanouchi; Noriko Hayami; Yuji Marui; Naoki Sawa; Michio Nakamura; Shinji Tomikawa; Kenmei Takaichi
Journal:  Intern Med       Date:  2011-11-01       Impact factor: 1.271

9.  Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients.

Authors:  V C Gandhi; H M Humayun; T S Ing; J T Daugirdas; V R Jablokow; S Iwatsuki; W P Geis; J E Hano
Journal:  Arch Intern Med       Date:  1980-09

10.  Tamoxifen therapy in kidney-transplant patients presenting with severe encapsulating peritoneal sclerosis after treatment for acute humoral rejection.

Authors:  Abdellatif Ould Mohamed; Nassim Kamar; Marie-Béatrice Nogier; Laure Esposito; Jean Pierre Duffas; Lionel Rostaing
Journal:  Exp Clin Transplant       Date:  2009-09       Impact factor: 0.945

View more
  1 in total

Review 1.  Encapsulating Peritoneal Sclerosis: Pathophysiology and Current Treatment Options.

Authors:  Rajesh M Jagirdar; Andreas Bozikas; Sotirios G Zarogiannis; Maria Bartosova; Claus Peter Schmitt; Vassilios Liakopoulos
Journal:  Int J Mol Sci       Date:  2019-11-16       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.